Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck

This page shows the latest Lundbeck news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market

Daily Brief: Lundbeck gets new leader, Recordati sold, GSK-backed firm prepares for market. ... A round-up from pharma, biotech and healthcare. Dunsire named new Lundbeck chief executive.

Latest news

More from news
Approximately 55 fully matching, plus 127 partially matching documents found.

Latest Intelligence

  • Digital disruption Digital disruption

    R&D, this time within psychiatric and neurological treatments, was in the mind of Lundbeck executives when they signed a drug research deal with IBM Watson Health in February. ... Starting with projects in schizophrenia and Parkinson’s disease,

  • Communiqué Awards 2014 Digital Publication Communiqué Awards 2014 Digital Publication

    See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

  • The Chinese diabetes challenge The Chinese diabetes challenge

    Last month's ChinaBio Partnering Forum in Suzhou, for example, was sponsored by (among others) AstraZeneca, Bayer, Bristol-Myers Squibb, Johnson &Johnson, Lilly, Lundbeck, Novo Nordisk and Roche.

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    825. Chelsea Therapeutics/ Lundbeck. Company acquisition. Includes Northera (droxidopa) for neurogenic orthostatic hypotension (approved).

  • Deal Watch table for May 2014 Deal Watch table for May 2014

    1, 030. Chelsea / Lundbeck. Company acquisition. US company with treatments for rare neurologic diseases.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 20 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics